Call for Abstract

20th Asia-Pacific Pharma Congress, will be organized around the theme “De Novo Advancements in Pharmaceutical Sciences”

Asia Pharma 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Asia Pharma 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Drug Regulations and Organizations
  • Track 1-2Regulations and Organizations
  • Track 1-3Global Pharma Products Registration
  • Track 1-4Intellectual Property Law for Generics and Innovator Rights
  • Track 1-5Safety and Quality Regulation in Labelling
  • Track 2-1Drug Discovery Research in Pharmacognosy
  • Track 2-2Industrial Pharmacognosy
  • Track 2-3Drugs from Natural Sources
  • Track 2-4Herbal Drug Analysis Methods
  • Track 2-5Pharmacoergasy
  • Track 3-1Pharmacoepidimiology and Pharmacotherapy
  • Track 3-2Drug Interactions and Adverse Drug Reactions
  • Track 3-3Pre-formulation Considerations
  • Track 3-4Pharmaceutical Technology
  • Track 3-5Advances in Pharmacodynamics & Pharmacokinetics
  • Track 4-1Nanotechnology in Drug Delivery Systems
  • Track 4-2Sustained Drug Delivery System
  • Track 4-3Recent Advances in Drug Delivery System
  • Track 4-4Pharmaceutical Nanotechnology
  • Track 4-5Nanotechnology and Therapeutic Delivery
  • Track 5-1Product Management
  • Track 5-2Physical Pharmacy Practice
  • Track 5-3Post- Marketing Surveillance
  • Track 5-4Supply Chain Management
  • Track 5-5Good Manufacturing Practices
  • Track 5-6Industrial Pharmaceutics
  • Track 5-7Drug Discovery and Development
  • Track 6-1Reverse Pharmacology
  • Track 6-2Regulatory Toxicology
  • Track 6-3Clinical Efficacy and Safety Evaluation
  • Track 6-4Drug Interactions and Pharmacological Compatibilities
  • Track 6-5Plant Toxicology
  • Track 7-1Chemistry of Natural Products
  • Track 7-2Advanced Medicinal Chemistry
  • Track 7-3Advances in Pharmaceutical Organic Chemistry
  • Track 7-4Molecular Drug Design
  • Track 7-5Green Techniques for Organic Synthesis and Medicinal Chemistry
  • Track 7-6Advances in Drug Discovery
  • Track 7-7Computational Chemistry
  • Track 8-1Novel Approaches to Analytical and Bioanalytical Methods
  • Track 8-2Bioanalytical Techniques
  • Track 8-3Chromatography and Techniques
  • Track 8-4Spectroscopic Techniques
  • Track 8-5Nuclear Magnetic Resonanace
  • Track 8-6Mass Spectroscopy
  • Track 8-7Regulatory Issues and Biosafety Challenges in Bioanalysis
  • Track 8-8Applications of Analytical and Bioanalytical Methods
  • Track 9-1Microbial Contamination
  • Track 9-2Intermediates, APIs, Excipients and Drug Substances
  • Track 9-3Critical Microbiology Quality Attributes
  • Track 9-4Strategies for Maintaining Non-sterile Manufacturing Environment
  • Track 9-5Antimicrobial Activity and Disinfection
  • Track 10-1Biomedical Data Engineering
  • Track 10-2Bioinformatics Engineering
  • Track 10-3Industrial Pharma Biotechnology
  • Track 10-4Genetics & Genetic Engineering
  • Track 10-5Tissue Engineering
  • Track 11-1Computational Chemistry
  • Track 11-2Protein Biosynthesis, Protein Folding and Global Protein Analysis and Function
  • Track 11-3Biomolecules
  • Track 11-4Molecular Drug Design
  • Track 11-5Structure Activity Relationship
  • Track 11-6Immunochemistry
  • Track 12-1Pharmacist Key Role in Treatment
  • Track 12-2Role of Clinical Pharmacist
  • Track 12-3Challenges in Compounding and Dispensing Pharmacy
  • Track 12-4Role of Hospital Pharmacists
  • Track 13-1Signal Detection in Drug Safety
  • Track 13-2Consulting on Risk Management
  • Track 13-3Adverse Event Reporting
  • Track 13-4Postmarketing Drug Safety
  • Track 14-1Research Methodology
  • Track 14-2Recent Updates on Clinical Trials
  • Track 14-3Clinical Molecular Genetics
  • Track 14-4Clinical Immunology
  • Track 14-5Clinical Drug Development and Therapeutics
  • Track 14-6Clinical Research and Methodology
  • Track 15-1Cancer Pharmcogenetics
  • Track 15-2Recent Advances in DNA Repair
  • Track 15-3Methods To Determine Biological Targeting
  • Track 15-4T Cell Modulation and Immune Response
  • Track 15-5Mutagenecity and Genotoxicity
  • Track 16-1Good Governance in Pharmacy
  • Track 16-2Ethics in Pharmacy
  • Track 16-3Future Trends in Green Pharmacy
  • Track 16-4Role of Community Pharmacist
  • Track 16-5Green Technologies in Pharmaceutical Industry
  • Track 17-1Herbal & Traditional Medicine
  • Track 17-2Natural Medicine Products
  • Track 17-3Nutraceuticals in Cancer Therapy
  • Track 17-4Dietary Supplements & Functional Foods
  • Track 17-5Prebiotics & Probiotics
  • Track 18-1Clinical Practice Guidelines
  • Track 18-2Patient Centered Pharmacy Practice
  • Track 18-3Global Technical Standards
  • Track 18-4Critical View of Pharmacy Education
  • Track 19-1Pharmaceutical Care Management
  • Track 19-2Health Care Management and Providers
  • Track 19-3Medical Billing Softwares
  • Track 19-4Medication Management Services
  • Track 20-1Regulatory Compliance
  • Track 20-2Risk Management
  • Track 20-3Patient Compliance
  • Track 20-4Data Integration